Giles Dixon
banner
gilesdixon.bsky.social
Giles Dixon
@gilesdixon.bsky.social
Respiratory trainee and Wellcome Trust PhD Fellow. University of Exeter. Interstitial lung disease and lung imaging
Reposted by Giles Dixon
The UK ILD Registry is designed to support hospitals in gaining actionable insights into key drivers for improved patient outcomes.

Read the Annual Report to learn more about our work and achievements in 2024 👉 brit-thoracic.uk/ILDRegistryReport24
May 21, 2025 at 10:02 AM
Reposted by Giles Dixon
In the FIBRONEER-IPF phase 3 trial, nerandomilast slowed disease progression in patients with idiopathic pulmonary fibrosis as compared with placebo. Full trial results: nej.md/4mgWcIU

#ATS2025 @atscommunity.bsky.social
May 18, 2025 at 9:20 PM
Reposted by Giles Dixon
Reposted by Giles Dixon
Looking for last minute revision questions for the #SCE? our free @brainscape.bsky.social deck is available here: www.brainscape.com/p/4MNSM-LH-C... Thanks to those people who commented on a couple of Qs with typos & one which was out of date - all now fixed! #RespEd #medsky #pulmsky #lungsky
Respiratory MRCP SCE - Online Flashcards by Laura-Jane Smith | Brainscape
Learn faster with Brainscape on your web, iPhone, or Android device. Study Laura-Jane Smith's Respiratory MRCP SCE flashcards now!
www.brainscape.com
March 8, 2025 at 9:48 AM
Reposted by Giles Dixon
IPF diagnosis is still delayed for many patients – over 36% experience symptoms for 2+ years before seeing a specialist.

The latest report shines a light on BTS Registry data findings.

👉 http://brit-thoracic.uk/ILDRegistryFindings

#ILD
February 27, 2025 at 12:00 PM
Reposted by Giles Dixon
Two new projects just published on our website are about using #AI to monitor and predict #LungDisease progression. Both led by @gilesdixon.bsky.social.

The first focuses on interstitial lung diseases, using AI to assess high-resolution computed tomography scans.

#Respiratory

bit.ly/3POI5vF
Could AI help with monitoring and predicting progression of interstitial lung disease?
Interstitial lung diseases (ILD) lead to around 1 in 100 deaths in the UK. Some people’s condition gets worse (also known as progression)…
bit.ly
January 27, 2025 at 10:36 AM
Reposted by Giles Dixon
📣 Call for US ban on crystalline silica-containing engineered stone 🪨

Used in artificial stone/"quartz" countertops, growing cause of preventable occupational 🫁 disease, Silicosis

Kudos Heinzerling et al.'s R/L
www.atsjournals.org/doi/abs/10.1...

@atsblueeditor.bsky.social @ats-eoph.bsky.social
January 5, 2025 at 4:21 PM
Reposted by Giles Dixon
Inspired by all the @bsky.app handles at #BTSWinter2024 (thank you @btsrespiratory.bsky.social) we've made the switch. Feeling a bit like the new kid at school! Please follow, recommend your fave follows and point us in the direction of good science! #RespIsBest #UniOfBristol
a little girl is smiling and saying hello there
ALT: a little girl is smiling and saying hello there
media.tenor.com
December 2, 2024 at 5:45 PM
Reposted by Giles Dixon
Ever wondered if steroids do more harm than good in Hypersensitivity Pneumonitis? Don’t worry, the trial that is needed is on the way!

rdn.nihr.ac.uk/news/south-w...
South West trust awarded £2m NIHR funding for global first respiratory study
The Royal Devon University Healthcare NHS Foundation Trust has received £2m from the National Institute for Health and Care Research (NIHR) for research into a health condition that adversely affects ...
rdn.nihr.ac.uk
November 22, 2024 at 12:29 PM
Reposted by Giles Dixon
November 20, 2024 at 4:39 PM